Blood samples analysis finds ESR1 gene mutations prevalent, associated with worse ove

[News]

The different mutations may predict different responses to everolimus.Among patients with estrogen receptor (ER)-positive, metastatic breast cancer, those who had a D538G and/or a Y537S mutation in...

More... (http://www.medicalnewstoday.com/releases/303937.php)